Search the Newsreel

Radico Khaitan Shares Drop Over 2% Amid Price Fall

Parabilis Medicines (PBLS) boosts cash above $1.1B after IPO and Regeneron deal

Parabilis Medicines, Inc. reported its Q2 2026 results, showing a significant increase in cash and cash equivalents to over $1.1 billion. This boost follows its June 2026 IPO, which generated $787.9 million in net proceeds, and a $50.0 million upfront payment from its collaboration …

SBC Medical Reports 13 Pct Rise In Q2 Revenue, Net Income Jumps 335 Pct

SBC Medical Group Holdings Inc. reported a 13% year-on-year increase in consolidated revenue to US$49 million for Q2 fiscal 2026, with net income surging by 335% to US$11 million. The company attributes this growth to strengthening underlying fundamentals, including the integration of healthcare and …

Retail giant debuts its first immersive sports store in Colorado

Dick's Sporting Goods has launched its first "House of Sport" location in Colorado, situated in Thornton. The grand opening will feature a three-day celebration with appearances by former and current Denver Broncos and Colorado Avalanche stars. This immersive sports store aims to offer a …

Medico Remedies standalone net profit rises 38.46% in the June 2026 quarter

MediciNova (MNOV) Reports Q2 Loss, Tops Revenue Estimates

MediciNova (MNOV) reported a Q2 loss of $0.05 per share, surpassing the Zacks Consensus Estimate of a $0.06 loss and improving from a $0.07 loss a year ago. The company also exceeded revenue estimates, posting $0.46 million against a $0.15 million consensus, though its …

Parabilis Medicines (PBLS) Earnings Date and Reports 2026

Form 8K Parabilis Medicines For: 13 August By Investing.com

The article is a brief financial news item from Investing.com, reporting on a Form 8K filing by Parabilis Medicines for August 13th. It provides no further details beyond stating the filing occurred on that date.

Earnings Flash (PBLS) Parabilis Medicines, Inc. Reports Q2 Revenue $148,000

Parabilis Medicines, Inc. (PBLS) reported its Q2 revenue as $148,000. The company, a clinical-stage biopharmaceutical firm, focuses on developing transformative medicines for "undruggable" protein targets using its proprietary Helicon platform. Analysts currently have a "BUY" consensus for PBLS with an average target price of …

Tenon outlines sacropelvic launches over next six to nine months following FDA 510(k) clearance

Earnings Call Insights: Tenon Medical (TNON) Q2 2026 MANAGEMENT VIEW * "Second quarter revenue was $1.3 million, an increase of 127% over the second quarter last year, and gross profit was $0.8 million, an increase of 232% over the prior year period." (CEO, President …

MediciNova (NASDAQ:MNOV) Announces Quarterly Earnings Results

MediciNova (NASDAQ:MNOV) exceeded quarterly earnings expectations, reporting a loss of $0.05 per share against an estimated $0.06 loss, and revenues of $0.46 million, significantly above the $0.07 million forecast. Despite the positive earnings surprise, the company experienced a slight dip in share price to …

Tenon Medical earnings missed by $3.95, revenue fell short of estimates

Medical Properties Trust declares $0.09 quarterly dividend

Medical Properties Trust Inc. announced a quarterly cash dividend of $0.09 per share of common stock. This dividend will be distributed on October 8, 2026, to shareholders recorded as of September 10, 2026. The company operates as a real estate investment trust focusing on …

MediciNova: Q2 Earnings Snapshot

This article provides a Q2 earnings snapshot for MediciNova. No further details are available in the provided content.

NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary

ICU Medical (ICUI) Q2 2026 Earnings Call Transcript

AK Medical Sets August Board Meeting to Review Interim Results and Dividend

Insider Stock Buying Reaches CN¥264.4m On Shanghai INT Medical Instruments

ICU Medical VP Daniel Woolson sells $982,264 in stock

Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc. (NASDAQ:ICUI), sold 5,417 shares of the company's common stock for $982,264 on August 13, 2026, at $181.33 per share. This sale occurred as ICUI shares are near their 52-week high, following strong Q2 results where …

Profound Medical (PROF) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer and Chairman - Arun Swarup MenawatPresident - Mathieu BurtnykChief Commercial Officer - Tom TamberrinoCorporate Controller - Matthew SobczykInvestor Relations - Stephen Kilmer TAKEAWAYS Revenue -- …

Rockwell Medical Inc (RMTI) (Q2 2026) Earnings Call Highlights: Revenue Up 11% and Cash Flow ...

ICU Medical (ICUI) officer Daniel Woolson sells 5,417 shares at $181.33

Daniel Woolson, VP and GM-Infusion Capital at ICU Medical Inc. (ICUI), sold 5,417 shares of common stock at $181.33 per share on August 13, 2026. After this transaction, Woolson directly holds 17,062 shares of ICU Medical common stock. The sale was not conducted under …

AVITA Medical (RCEL) Q2 2026 Earnings Call Transcript

Earnings call transcript: Tenon Medical posts strong growth in Q2 2026

Tenon Medical reported strong revenue growth of 127% year-over-year in Q2 2026, reaching $1.3 million, but still posted a wider net loss of $4.1 million and missed analyst expectations for both revenue and earnings. Despite the financial miss, the company saw significant gross margin …

MNOV: Q2 2026 revenue grew and net loss narrowed, with cash reserves supporting operations into 2027

MediciNova (MNOV) reported a revenue increase to $0.5M in Q2 2026, primarily from Mayo ALS study services, while significantly narrowing its net loss to $2.3M. Research and development expenses decreased year-over-year, and the company's $25.4M in cash reserves are projected to fund operations until …

Strata Critical Medical (SRTA) director Reginald Love sells 5,091 shares at $5.75

Strata Critical Medical, Inc. director Reginald Love sold 5,091 shares of Class A common stock at $5.75 per share on August 10, 2026. Following this transaction, his direct holdings in the company amount to 146,481 shares. The sale was reported in an open market …

Adagio Medical Highlights VT Ablation Progress in Presentation

Modern Chinese Medicine Group Sets August Board Meeting for Interim Results and Dividend Review

Farallon funds disclose 13.6M-share RVMD stake in Schedule 13G/A filing

Farallon Capital Management, L.L.C. and its affiliated funds have disclosed a beneficial ownership of 13,564,149 shares, or 6.4%, of Revolution Medicines, Inc. (RVMD) common stock, according to a recent Schedule 13G/A filing. This includes 13,550,796 shares and 120,085 common stock purchase warrants, with the …

Vivani Medical (NASDAQ:VANI) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Vivani Medical (NASDAQ:VANI) reported a quarterly loss of $0.07 per share, exceeding analyst estimates by $0.01. Despite beating expectations, shares fell 2.2% to $1.34. The company has an average "Hold" rating from analysts with a target price of $3.75, and director Gregg Williams recently …

Tenon Medical, Inc. 2Q 2026: Revenue $1.279M, Net loss $(4.05M), EPS $(12.35) — 10-Q Summary

Tenon Medical, Inc. reported its second-quarter 2026 results, showing revenue of $1.279 million, a net loss of $(4.05 million), and a diluted loss per share of $(12.35). Revenue more than doubled year-over-year, driven by increased procedure volumes and the acquisition of the SImmetry+ System. …

Tenon Medical (TNON) lifts SI joint revenue but flags going-concern risk

Tenon Medical (TNON) reported increased revenue for the quarter ended June 30, 2026, reaching $1.3 million, up from $0.6 million a year prior, driven by higher SI joint procedure volumes and contributions from its SImmetry+ system. Despite revenue growth and improved gross margins, the …

Medical Properties Trust, Inc. Declares Regular Quarterly Dividend, Payable on October 8, 2026

Medical Properties Trust, Inc. announced a regular quarterly cash dividend of $0.09 per share of common stock. This dividend will be paid on October 8, 2026, to shareholders of record as of September 10, 2026. The announcement was made by the company's Board of …

Vivani Medical: Q2 Earnings Snapshot

Renaissance Technologies (UTMD) discloses 5.52% ownership in Utah Medical Products

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have reported a beneficial ownership of 175,814 shares, or 5.52%, in Utah Medical Products Inc. as of June 30, 2026. Both entities hold sole voting and dispositive power over these shares. The filing, a Schedule 13G/A, …

IceCure Medical (Nasdaq: ICCM) updates filing for 533,334 warrant-share resales

IceCure Medical Ltd. has filed a post-effective amendment to its Form F-1 to update financial information and maintain the effectiveness of a resale registration. This filing concerns the potential resale of up to 533,334 Ordinary Shares by existing selling shareholders, which are issuable upon …